Found: 5
Select item for more details and to access through your institution.
Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
- Published in:
- Rheumatology, 2015, v. 54, n. 7, p. 1226, doi. 10.1093/rheumatology/keu460
- By:
- Publication type:
- Article
Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry.
- Published in:
- Rheumatology, 2012, v. 51, n. 9, p. 1618, doi. 10.1093/rheumatology/kes074
- By:
- Publication type:
- Article
Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Deriving common comorbidity indices from the MedDRA classification and exploring their performance on key outcomes in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 3, p. 548, doi. 10.1093/rheumatology/kex440
- By:
- Publication type:
- Article